WNK2 and melanoma: Therefore, uncovering the hidden downstream effectors of the mitogen-activated protein kinase (MAPK)/extracellular signal-regulated kinase (ERK) pathway can provide clues to understand melanoma biology and improve the therapeutic efficacy of targeted therapy.